| Financial Year |
March 31 2023 |
| Monetary Funds |
173,441,137.89 |
| Held-for-trading Financial Assets |
273,459,893.18 |
| Notes Receivable |
-- |
| Accounts Receivable |
54,287,010.07 |
| Advances to Suppliers |
5,743,693.11 |
| Other Receivables |
24,573,840.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,282,125,304.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,486,541.23 |
| Total Current Assets |
4,851,117,420.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
93,927.64 |
| Investment Properties |
560,216,601.35 |
| Fixed Assetes |
20,812,148.77 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,992,877.19 |
| Deferred Income Tax Assets |
59,370,256.85 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
656,697,082.25 |
| Total Assets |
5,507,814,502.77 |
| Short-Term Loans |
46,682,302.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
420,510,933.32 |
| Accounts Received In Advance |
5,428,233.81 |
| Employee Compensation Payable |
31,583,350.13 |
| Taxes Payable |
61,205,538.67 |
| Interest Payable |
16,535,277.94 |
| Dividend Payable |
-- |
| Other payables |
561,998,000.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,412,023.44 |
| Other Current Liabilities |
3,078,103.61 |
| Sub-Total of Current Liabilities |
1,176,994,532.46 |
| Long-term Loans |
74,961,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,096,348.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,090,620.21 |
| Total Liabilities |
1,255,085,152.67 |
| Paid-In Capital(Or Share Stock) |
1,011,660,000.00 |
| Capital Surplus |
978,244,910.11 |
| Surplus Reserve |
275,253,729.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,677,501,388.96 |
| Minority Stockholder's Interest |
282,243,003.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,970,486,346.38 |
| Owner's Equity（Stockholder's Equity） |
4,252,729,350.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,507,814,502.77 |
